Skip to main content

Table 1 Clinical and genetic characteristics of mutation carriers

From: Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension

 

Patient

Gender

Age

Clinical classification

Positive family history

Gene

Type of mutation

Gene region

Mutation

FM clinically assessed

Affected FM

Unaffected FM carrying mutation

I/HPAH

1

A8317

f

7

IPAH

no

BMPR2

deletion

Exons 4-5

c.419-?_621 + ?del

2

-

1

2

A15678

f

12

IPAH

?

BMPR2

nonsense

Exon 10

c.1297C > T (p.Q433X)

-

1 (n. a.)

n. a.

3

A8205

m

5

IPAH

no

BMPR2

missense (de novo)

Exon 11

c.1472 G > A (p.R491Q)

3

-

-

4

A16735

m

12

IPAH

?

BMPR2

frameshift

Exon 12

c.2668DelA (p.R890GfsX6) *

-

? (adopted)

n. a.

5

A8643

m

5.5

IPAH; syncope

no

BMPR2

Splicing defect?

Intron 3

c.419-10 T > C *#

3

-

2

6

A3385

f

3

IPAH; syncope

no

ACVRL1

missense

Exon 7

c.950 T > C (p.I317T) *

7

-

3

7

A6620

m

3.5

HPAH

yes (HHT + HPAH)

ACVRL1

missense

Exon 10

c.1451 G > A (p.R484Q)

6

2 (one HHT)

1

8

A15836

f

1.5

IPAH

no

ENG

missense

Exon 5

c.640 G > A (p.G214S)

4

-

2

CHD-APAH

9

C6710

f

2

CHD-APAH (VSD); Fetal alcohol syndrome

Yes (HPAH)

BMPR2

deletion

Exon 1

c.1-?_76 + ?del

1

3 (all †, not tested)

1

10

C3783

m

13

CHD-APAH (ASDII); Congenital hip dislocation

no

ENG

missense

Exon 12

c.1633 G > A (p.G545S)

6

-

1

  1. *marked mutations are described for the first time in this study; ? = unknown, n. a. = not available; FM family member; ASD atrial septal defect; VSD Ventricular septal defect; HHT hereditary hemorrhagic telangiectasia; † deceased, # unclassified: mutation or non-deleterious polymorphism.